GENH Stock Price, News & Analysis
Company Description
GENH (OTC: GENH) is a publicly traded drug manufacturers—specialty & generic company in the Healthcare sector. The company has a market capitalization of $25.3M.
GENH stock has declined 60.0% over the past year.
This page provides a comprehensive overview of GENH stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
GENH (GENH) stock. Over the past 12 months, the stock has lost 60.0%. At a market capitalization of $25.3M, GENH is classified as a micro-cap stock with approximately 113.2M shares outstanding.
Latest News
GENH has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 1 with negative movement. Key topics include crypto, conferences. View all GENH news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
GENH Company Profile & Sector Positioning
GENH (GENH) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector.
Investors comparing GENH often look at related companies in the same sector, including (CANBD), Vencanna Ventures (TPPRF), Aytu Biopharma Inc (AYTU), (LNDC), and (MNKPF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GENH's relative position within its industry.